The Neurodegeneration Revolution: Emerging Therapies and Sustainable Solutions
Editat de Trideva Sastri Koduru, Riyaz Ali M Osmani, Ekta Singh, Suman Duttaen Limba Engleză Paperback – 20 noi 2024
- Explores emerging therapies such as gene therapy, stem cell therapy, and nanoparticle-mediated drug delivery, as well as sustainable green nanotechnology
- Offers practical guidance for healthcare professionals and caregivers on how to effectively manage neurodegenerative diseases
- Explores the application of Artificial Intelligence and Machine Learning in the treatment of neurodegenerative diseases
Preț: 709.83 lei
Preț vechi: 930.03 lei
-24% Nou
Puncte Express: 1065
Preț estimativ în valută:
135.84€ • 139.11$ • 112.100£
135.84€ • 139.11$ • 112.100£
Carte tipărită la comandă
Livrare economică 11-25 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443288227
ISBN-10: 0443288224
Pagini: 628
Dimensiuni: 191 x 235 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0443288224
Pagini: 628
Dimensiuni: 191 x 235 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
Cuprins
Section 1: Neurodegeneration and Basics
1. Introduction to Neurodegeneration
2. Mechanisms of Neurodegeneration
3. Risk Factors and Genetic Predisposition
4. Diagnosis and Management of Neurodegenerative Diseases
Section 2: Established Therapies for Managing Neurodegeneration
5. Current Pharmacological Treatments
6. Non-Pharmacological Therapies
7. Nutritional Interventions
8. Lifestyle Changes for Neurodegeneration Prevention and
Management
Section 3: Advanced Therapies and Novel - New Age Delivery Systems
9. Gene Therapy for Neurodegeneration
10. Stem Cell Therapy for Neurodegeneration
11. Nanoparticle-Mediated Drug Delivery for Neurodegenerative
Diseases
12. Exosomes and Extracellular Vesicles for Neurodegenerative
Diseases
Section 4: Sustainable Green Nanotechnology and Integration of AI/ML for
Developing Nano Carriers
13. Sustainable green nanotechnology and its potential
for developing nanocarriers for neurodegenerative diseases
14. AI/ML in the development of nanocarriers
15. Benefits of integrating sustainable green nanotechnology and AI/ML for the development of nanocarriers.
16. Challenges and ethical considerations
Section 5: Emerging Frontiers in Neurodegenerative Disease Management
17. Biomarker research for neurodegenerative diseases
18. Ethical and social implications of managing neurodegenerative diseases
19. Caregivers and the management of neurodegenerative diseases
20. Global burden of neurodegenerative diseases
Section 6: Clinical Trials and Recent Research, Future Directions, and Conclusion
21. Clinical Trials for Neurodegenerative Diseases
22. Recent Research in Neurodegenerative Diseases
23. Future Directions for Neurodegenerative Disease Management
24. Conclusion: Challenges and Opportunities in Neurodegenerative
Diseases Management
1. Introduction to Neurodegeneration
2. Mechanisms of Neurodegeneration
3. Risk Factors and Genetic Predisposition
4. Diagnosis and Management of Neurodegenerative Diseases
Section 2: Established Therapies for Managing Neurodegeneration
5. Current Pharmacological Treatments
6. Non-Pharmacological Therapies
7. Nutritional Interventions
8. Lifestyle Changes for Neurodegeneration Prevention and
Management
Section 3: Advanced Therapies and Novel - New Age Delivery Systems
9. Gene Therapy for Neurodegeneration
10. Stem Cell Therapy for Neurodegeneration
11. Nanoparticle-Mediated Drug Delivery for Neurodegenerative
Diseases
12. Exosomes and Extracellular Vesicles for Neurodegenerative
Diseases
Section 4: Sustainable Green Nanotechnology and Integration of AI/ML for
Developing Nano Carriers
13. Sustainable green nanotechnology and its potential
for developing nanocarriers for neurodegenerative diseases
14. AI/ML in the development of nanocarriers
15. Benefits of integrating sustainable green nanotechnology and AI/ML for the development of nanocarriers.
16. Challenges and ethical considerations
Section 5: Emerging Frontiers in Neurodegenerative Disease Management
17. Biomarker research for neurodegenerative diseases
18. Ethical and social implications of managing neurodegenerative diseases
19. Caregivers and the management of neurodegenerative diseases
20. Global burden of neurodegenerative diseases
Section 6: Clinical Trials and Recent Research, Future Directions, and Conclusion
21. Clinical Trials for Neurodegenerative Diseases
22. Recent Research in Neurodegenerative Diseases
23. Future Directions for Neurodegenerative Disease Management
24. Conclusion: Challenges and Opportunities in Neurodegenerative
Diseases Management